000 | 01238 a2200373 4500 | ||
---|---|---|---|
005 | 20250512092805.0 | ||
264 | 0 | _c19680826 | |
008 | 196808s 0 0 eng d | ||
022 | _a0041-1132 | ||
024 | 7 |
_a10.1111/j.1537-2995.1968.tb04889.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRosenfield, R E | |
245 | 0 | 0 |
_aImmunologic suppression of primary Rh antibody formation. _h[electronic resource] |
260 |
_bTransfusion _c |
||
300 |
_a125-6 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aAntibody Formation |
650 | 0 | 4 |
_aErythroblastosis, Fetal _xprevention & control |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHemagglutination Tests |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunity, Active |
650 | 0 | 4 | _aImmunity, Maternally-Acquired |
650 | 0 | 4 | _aImmunization |
650 | 0 | 4 | _aIodine Isotopes |
650 | 0 | 4 | _aPregnancy |
650 | 0 | 4 |
_aPregnancy Complications, Hematologic _xprevention & control |
650 | 0 | 4 | _aRabbits |
650 | 0 | 4 | _aRh-Hr Blood-Group System |
650 | 0 | 4 |
_agamma-Globulins _xtherapeutic use |
773 | 0 |
_tTransfusion _gvol. 8 _gno. 3 _gp. 125-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1537-2995.1968.tb04889.x _zAvailable from publisher's website |
999 |
_c4178771 _d4178771 |